Altimmune
ALT
25 hedge funds and large institutions have $1.32M invested in Altimmune in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less ownership
Funds ownership: 0.29% → 0.28% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
4% less funds holding
Funds holding: 26 → 25 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
16% less capital invested
Capital invested by funds: $1.57M → $1.32M (-$248K)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$848K |
| 2 |
Renaissance Technologies
New York
|
+$225K |
| 3 |
Bank of New York Mellon
New York
|
+$43.5K |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$34.8K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$32.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$70.7K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$49K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$25.1K |
| 4 |
BlackRock
New York
|
-$19.3K |
| 5 |
Millennium Management
New York
|
-$19K |
ALT Hedge Fund Activity: Q2 2018 in Review
25 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Altimmune (ALT) for Q2 2018, worth a combined $1.32M — down 16% from $1.57M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ALT and 6 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $848K. The largest seller was Acadian Asset Management, exiting entirely with an estimated $70.7K sold.
- 25 institutional investors held Altimmune (ALT) as of Q2 2018, down from 26 in Q1 2018.
- Funds reported $1.32M of Altimmune stock for Q2 2018, down 16% quarter-over-quarter.
- 6 funds opened new Altimmune positions in Q2 2018 and 7 closed out, a net change of -1 holder.
- The largest Altimmune buyer in Q2 2018 was Hudson Bay Capital Management, an estimated $848K added.
- The largest Altimmune seller in Q2 2018 was Acadian Asset Management, an estimated $70.7K sold.
Based on aggregated 13F filings for Q2 2018.